Brillia Health Cold-Flu Recovery: Homeopathic Product Information

BRILLIA HEALTH COLD-FLU RECOVERY- lapine interferon gamma immune globulin, lapine histamine immune globulin and lapine cd4 immune globulin tablet
Hadaf LLC

Disclaimer: This homeopathic product has not been evaluated by the Food and Drug Administration for safety or efficacy. FDA is not aware of scientific evidence to support homeopathy as effective.

Active Ingredients

Lapine interferon gamma immune globulin 12C, 30C, 50C Purpose: enchance magnitude of immune response

Lapine histamine immune globulin 12C, 30C, 50C Purpose: reduce histamine and inflammation response

Lapine CD4 immune globulin 12C, 30C, 50C Purpose: Enhance functional activity of immune system

Purpose

Homeopathic,

Enhance magnitude of immune response

Reduce histamine and inflammation response

Enhance functional activity of immune system

Uses

• Shorten the duration of flu and cold symptoms
• Reduce severity of flu and cold symptoms, including nasal congestion, cough and sore/itchy throat

Warnings

Ask a doctor or pharmacist before use if you are lactose-intolerant.


Stop use and ask a doctor if symptoms persist or worsen.


If pregnant or breast-feeding , ask a health professional before use.


Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away.


A llergic (hypersensitivity) reactions may occur i n very rare cases.


Do not use if known sensitivity to Brillia Health Cold-Flu Recovery or any of its ingredients exists.

Ask a doctor

Ask a doctor or pharmacist before use if you are lactose-intolerant.

Stop use and ask a doctor if symptoms persist or worsen.

If pregnant or breast-feeding, ask a health professional before use.

Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away.

Allergic Reaction

Allergic (hypersensitivity) reactions may occur i n very rare cases.

Do not use if known sensitivity to Brillia Health Cold-Flu Recover y or any of its ingredients exists.

Directions


• For adults and children 1 year and older.
• Hold tablet in mouth until completely dissolved, without food. If necessary, tablet can be taken dissolved in 1 tablespoon of drinking water.
• Day 1: 8 tablets total for the first day
1 tablet every 30 minutes for the first 2 hours
(a total of 5 tablets over 2 hours),
1 tablet taken 3 more times at equal intervals
(a total of 3 tablets over the remainder of the day).
• Days 2 to 5: 1 tablet 3 times a day
(at equal intervals).

Other Information

• Store in original package below 25°C or 77°F.
• Do not use if blister pack is torn or broken.

Inactive Ingredients

Lactose monohydrate, Magnesium stearate, Microcrystalline cellulose.

40 Tablets NDC: 72123-006-01

LABEL 1
(click image for full-size original)
BRILLIA HEALTH COLD-FLU RECOVERY
lapine histamine immune globulin (12c, 30c, 50c), lapine interferon gamma immune globulin (12c, 30c, 50c), lapine cd4 immune globulin (12c, 30c, 50c) tablet
Product Information
Product Type HUMAN OTC DRUG Item Code (Source) NDC:72123-006
Route of Administration ORAL DEA Schedule
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
LAPINE INTERFERON GAMMA IMMUNE GLOBULIN (LAPINE INTERFERON GAMMA IMMUNE GLOBULIN) LAPINE INTERFERON GAMMA IMMUNE GLOBULIN 12 [hp_C]
LAPINE HISTAMINE IMMUNE GLOBULIN (LAPINE HISTAMINE IMMUNE GLOBULIN) LAPINE HISTAMINE IMMUNE GLOBULIN 12 [hp_C]
LAPINE CD4 IMMUNE GLOBULIN (LAPINE CD4 IMMUNE GLOBULIN) LAPINE CD4 IMMUNE GLOBULIN 12 [hp_C]
Inactive Ingredients
Ingredient Name Strength
LACTOSE MONOHYDRATE
MICROCRYSTALLINE CELLULOSE
MAGNESIUM STEARATE
Product Characteristics
Color white Score score with uneven pieces
Shape ROUND (round tablets) Size 9mm
Flavor Imprint Code other
Contains
Packaging
# Item Code Package Description Multilevel Packaging
1 NDC:72123-006-01 2 BLISTER PACK in 1 BOX contains a BLISTER PACK
1 20 TABLET in 1 BLISTER PACK This package is contained within the BOX (72123-006-01)
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
unapproved homeopathic 07/31/2020
Labeler — Hadaf LLC (094114708)
Establishment
Name Address ID/FEI Operations
Santonika Uab 520214047 manufacture (72123-006)

Revised: 08/2020 Hadaf LLC

HomeoLabels.com provides trustworthy package insert and label information about marketed homeopathic remedies as submitted by manufacturers to the U.S. Food and Drug Administration. Package information is not reviewed or updated separately by HomeoLabels.com. Every individual package label entry contains a unique identifier which can be used to secure further details directly from the U.S. National Institutes of Health and/or the FDA.

Main Sections

Homeopathy Information by RSS

We source our database directly from the FDA's central repository of homeopathic remedy labels and package inserts, under the Structured Product Labeling standard. Our material is not intended as a substitute for direct consultation with a qualified health professional.

Terms of Use | Copyright © 2021. All Rights Reserved.